Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients

NCT00270894 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasm

Interventions

DRUG: epirubicin
DRUG: cyclophosphamide
DRUG: docetaxel
DRUG: trastuzumab

Sponsor

Accelerated Community Oncology Research Network

Collaborators

[object Object]